Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Common Equity (2016 - 2025)

GeoVax Labs' Common Equity history spans 16 years, with the latest figure at $3.8 million for Q4 2025.

  • Quarterly results put Common Equity at $3.8 million for Q4 2025, down 24.23% from a year ago — trailing twelve months through Dec 2025 was $3.8 million (down 24.23% YoY), and the annual figure for FY2025 was $3.8 million, down 24.23%.
  • Common Equity for Q4 2025 was $3.8 million at GeoVax Labs, down from $4.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $31.8 million in Q3 2022 to a low of -$2.3 million in Q2 2024.
  • The 5-year median for Common Equity is $8.8 million (2023), against an average of $12.3 million.
  • The sharpest move saw Common Equity tumbled 113.45% in 2024, then skyrocketed 14451.87% in 2025.
  • Year by year, Common Equity stood at $4.4 million in 2021, then soared by 509.85% to $26.6 million in 2022, then plummeted by 78.33% to $5.8 million in 2023, then dropped by 12.4% to $5.0 million in 2024, then decreased by 24.23% to $3.8 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $3.8 million, $4.9 million, and $2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.